Skip to content

Patient recorded indexing measurements

Patient recorded indexing measurements - PRIMs

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54788
Enrollment
322
Registered
2019-02-20
Start date
2019-09-04
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer cachexia - emaciation in cancer

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Age >= 18 • Diagnosed with cancer • Planned for primary curative cancer treatment (surgery or chemotherapy)

Exclusion criteria

Exclusion criteria: • ASA-classification V, • severe liver cirrhosis Child grade C, • end stage renal disease requiring dialysis, • severe heart disease New York Heart Association class IV, • chronic obstructive pulmonary disease (COPD) requiring (home)oxygen therapy, • Patients must be *mobile*. They may not be bedridden or in a wheelchair.

Design outcomes

Primary

MeasureTime frame
The primary objective of this study is to obtain accurate data regarding physical activity and body weight loss over time in patients with cancer, who are undergoing primary curative cancer therapy (surgery or chemotherapy), and relate this to adverse events of their treatment (postoperative complications and/or chemotoxicity).

Secondary

MeasureTime frame
1) Evaluation of the association between body weight and physical activity in patients with cancer receiving primary curative cancer treatment. 2) evaluation of the association between body weight changes, physical activity and body composition analysis in relation to survival in patients with cancer. 3) Evaluation of the association between body weight changes, physical activity and body composition analysis in relation to radiological or pathological treatment response in patients with cancer

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)